Long-term peripheral retinal vascular behavior in retinopathy of prematurity patients treated with ranibizumab intravitreal injection as monotherapy using fluorescein angiography

Table 1 Baseline characteristics of children who were treated with IVR as monotherapy for ROP type I

Number of patients	22
Number of eyes	44
Male / Female	13 / 9
BW, mean ± SD (median, range)	707.4 ± 325.21 g (625, 510–2100)
GA, mean ± SD (median, range)	24.67 ± 1.37 weeks (24, 23–28)
PMA at treatment, mean ± SD (median, range)	36.11 ± 2.96 weeks (36, 32–46)
PMA at FA, mean ± SD (median, range)	215.32 ± 40.94 weeks (209, 155–288)

GA, Gestational age, BW Birth weight, PMA Post menstrual age, FA Fluorescein angiograms

ISSN: 2056-9920